Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Bank of Russia wants to fine Tinkoff Insurance ₽7.7 billion

6/6/24 T

Element's shares will start trading on the Moscow Exchange

6/5/24 ELMT

Rostelecom wants to become an operator of electric charging infrastructure

6/5/24 RTKM

Shareholders of SFI approved dividends for 2023

6/5/24 SFIN

Mechel reduced pig iron and steel output by 16% in Q1

6/5/24 MTLR

Rostelecom will launch a platform for obtaining bank guarantees

6/5/24 RTKM

Ozon will build a logistics complex in Primorye

6/5/24 OZON

Board of Directors of United Heavy Machinery recommended that dividends be paid for 2023

6/5/24 OMZZP

Tinkoff became T-Bank

6/5/24 T

Shareholders of Seligdar approved dividends for 2023

6/5/24 SELG